PG® 25 Capsule: Each capsule contains Pregabalin INN 25 mg.
PG® 50 Capsule: Each capsule contains Pregabalin INN 50 mg.
PG® 75 Capsule: Each capsule contains Pregabalin INN 75 mg.
PG® is the preparation of Pregabalin, used for the treatment of neuropathic pain and as an adjunctive therapy for partial seizures epilepsy. The active substance, Pregabalin, is a gamma-aminobutyric acid analogue (S)-3-(aminomethyl)-5-methylhexanoic acid. Pregabalin binds to an auxiliary subunit (α2-δ protein) of voltage-gated calcium channels in the central nervous system, potently displacing [H]- gabapentin.
The dose range is 150 to 600 mg per day given in either two or three divided doses.
PG® may be taken with or without food.
Neuropathic pain:
Epilepsy:
Fibromyalgia:
Post Herpetic Neuralgia:
Generalized Anxiety Disorder:
Dose should be adjusted in patients with reduced renal function.
Administration in Renal Impairment:
Pregabalin clearance is directly proportional to creatinine clearance, so dosage reduction in patient with compromised renal function must be adjusted according to creatinine clearance (Clcr).
<!-- formula-not-decoded -->.
Discontinuation of Pregabalin:
In accordance with current clinical practice, if Pregabalin has to be discontinued, it is recommended to withdraw gradually over a minimum of 1 week.
Pregnancy Category C: Breast-feeding is not recommended during treatment with Pregabalin.
It is advised not to drive a car or operating dangerous machineries. While taking Pregabalin, some patients with diabetes who gain weight may need to alter their diabetic medications. Alcohol should be avoided while taking this medicine. Patients with renal insufficiency should take Pregabalin with proper caution & dose adjustment should be done according to creatinine clearance.
Store in a dry place & away from light. Keep out of reach of children.